EVE Investments Limited announced that in mid-December it undertook a product launch in China to Hunan Yandi Bioengineering (Yandi), a leading green life and health care distributor and one of China's direct selling organizations with over one million members in its distribution network. Meluka Australia showcased its unique range of honey products to Yandi's direct sales and marketing network at its annual direct sales activity event, held in December 2019 for an audience of over 1,500 members of Yandi's sales team. Yandi have underlined their interest in Meluka Australia's tea tree honey, native raw honey and tea tree oil products, and to sell Meluka Australia branded products into China for the Company as it proceeds to scale up its commercialisation in the region.

The company announced it has received its first purchase order for its honey products. The order comprises 21,144 units of Meluka Australia's honey and underlines the significant commercial potential for its honey range in China and the Asia Pacific region. The purchase order is in line with normal commercial terms received by the Company from distributors. The product for the Chinese market is currently being manufactured at EVE's Alstonville facility in northern New South Wales, Australia, with shipment set to commence at the end of January.